Skip to main content
SNYRQ logo

SNYRQ · Synergy CHC Corp.

Track SNYRQ — free
$0.00 At close · Nov 10
Market Cap
$2,980
Shares
14.90M
Volume · Nov 10 1383 Avg daily vol (3M) 33.86M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–2.34 Avg vol 30d393K Short int575K · 3.9% of shares · 15.2d Short vol44% Last earningsMay 14, 2026 DataOct 2024–Nov 2026 Filing10-Q · May 14

Latest documents

2026
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$27.70M
Trailing 12 months
Net income (TTM)
−$15.79M
Trailing 12 months
Revenue growth YoY
-32.8%
Year over year
Operating margin
-39.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$27.46M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+31.8%
Year over year · more shares
Price change (1Y)
-100.0%
Trailing year
Short interest
3.9%
Latest settlement · 15.2 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 22.9 · elevated Equity put/call 0.73
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −100%
below
Price vs 50-day avg −100%
below
RSI (14) 40
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −97%
trailing
6-month return −100%
trailing
YTD return −100%
this year
Relative strength −101%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-93% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.86% of shares out · ▼ -0.1% MoM · 15.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 2-yr low, contrarian setup
Squeeze score 45
elevated · 0–100
Fundamentals
Poor
Revenue growth −13%
Y/Y
Gross margin 67%
contracting
EPS growth −554%
Y/Y
Free cash flow $-2.7M
Balance sheet $22.5M
net debt
Quant / Vol
risk profile
Very High
Volatility 977%
annualized · 1-yr
Max drawdown −100%
past year
ATR 7350.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2025
Same-store sales lift · once the TV advertising is up and running at least 15%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−100% Bearish
Price vs 50-day avg
−100% Bearish
RSI (14)
40 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-93% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.86% of shares out · ▼ -0.1% MoM · 15.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $2
vs 200-day avg -100% vs 50-day avg -100%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Distribution — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SNYRQ
Synergy CHC Corp.
this stock
$2,980 -100.0% -12.8% — 3.9%
MCK
Mckesson Corp
$127.58B +34.7% +3.1% 28.5 1.7%
COR
Cencora, Inc.
$68.11B +5.7% +9.3% 26.5 1.7%
CAH
Cardinal Health Inc
$65.61B +38.1% +14.2% — 3.3%
HSIC
Henry Schein Inc
$9.39B +12.4% +5.9% 23.3 8.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1
% held
0.0%
Net QoQ
-672.5K sh
Top holder
BARCLAYS PLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
574.9K
Days to cover
15.2d
Change
-521 sh
View
Short Volume
Short vol %
44%
As of
Nov 10, 2026
Short Total
View
Fails to Deliver
FTD shares
71.5K
Value
$2.1K
As of
Sep 23, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$30.4M
Net income (FY)
$-12.3M
EPS diluted
$-1.27
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 16, 2026
This year
20
View
Earnings & Events
Webcasts
Last webcast
May 14, 2026
View
Investor Relations
Latest news
Synergy CHC Corp. Announces Recei…
Published
Aug 21, 2026
View

Performance

5D 20D 120D MTD YTD
SNYRQ -98.0% -97.1% -100.0% +0.0% -100.0%
SPY -0.6% -3.6% +1.2% -0.8% +10.0%
vs SPY -97.4% -93.5% -101.1% +0.8% -110.0%